Bruce Power receives regulatory approval to produce medical Lu-177

Canada’s Nuclear Waste Management Organization, a not-for-profit organization responsible for the long-term management of the country’s intermediate- and high-level radioactive waste, is...

Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at...

The Canadian government has announced up to C$50 million ($36.8 million) in funding for predevelopment work to study the feasibility of building 4,800 megawatts of new generating capacity at...

According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To ...

The OECD Nuclear Energy Agency is hosting a workshop on the economics of small modular reactors in Ottawa, Canada, on February 27, 2024.The workshop will be an in-person event, with no hybrid...

Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the...

The Canadian Nuclear Safety Commission has decided to amend Canadian Nuclear Laboratories’ operating license for the Chalk River Laboratories, allowing the construction of a near surface...

Powering our Economy and the World with Clean Energy—Our Path Forward to 2035 is a new document released by the province of New Brunswick, Canada, that “outlines a 12-year energy road map...